SHANGHAI–(BUSINESS WIRE)–Lufax Holding Ltd (�Lufax or the Company) (NYSE: LU), a leading technology-empowered personal financial services platform in China, today announced that it plans to release its third quarter 2021 financial results after the market closes on Tuesday, November 9, 2021.
The Companys management will hold an earnings conference call at 8:00 P.M. U.S. Eastern Time on Tuesday, November 9, 2021 (9:00 A.M. Beijing Time on Wednesday, November 10, 2021) to discuss the financial results. For participants who wish to join the call, please complete online registration using the link provided below in advance of the conference call. Upon registering, each participant will receive a set of participant dial-in numbers, the Direct Event passcode, and a unique access PIN, which can be used to join the conference call.
Registration Link: https://dpregister.com/sreg/10161835/ef8b58027f
A replay of the conference call will be accessible through November 16, 2021 (dial-in numbers: +1 (877) 344-7529 or +1 (412) 317-0088; replay access code: 10161835). A live and archived webcast of the conference call will also be available at the Companys investor relations website at https://ir.lufaxholding.com.
About Lufax
Lufax Holding Ltd is a leading technology-empowered personal financial services platform in China. Lufax Holding Ltd primarily utilizes its customer-centric product offerings and offline-to-online channels to provide retail credit facilitation services to small business owners and salaried workers in China as well as tailor-made wealth management solutions to Chinas rapidly growing middle class. The Company has implemented a unique, capital-light, hub-and-spoke business model combining purpose-built technology applications, extensive data, and financial services expertise to effectively facilitate the right products to the right customers.
Contacts
Investor Relations Contact
Lufax Holding Ltd
Email: Investor_Relations@lu.com
ICR, LLC
Robin Yang
Tel: +1 (646) 308-0546
Email: lufax.ir@icrinc.com
Quarter End AUM of $31.7 billion; Average AUM of $30.7 billion for the First Quarter…
SYDNEY--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for patients…
DUBLIN--(BUSINESS WIRE)--The "Nepal International Remittance Market Business and Investment Opportunities - Analysis by Transaction Value…
DUBLIN--(BUSINESS WIRE)--The "Thailand International Remittance Market Business and Investment Opportunities - Analysis by Transaction Value…
Functioning Like a “Central Nervous System” for Data and AI, Atlan is Crafting a Future-Proof…
DUBLIN--(BUSINESS WIRE)--The "Malaysia International Remittance Market Business and Investment Opportunities - Analysis by Transaction Value…